1. Home
  2. PLSE vs GBDC Comparison

PLSE vs GBDC Comparison

Compare PLSE & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$47.02

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

HOLD

Current Price

$13.17

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
GBDC
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
PLSE
GBDC
Price
$47.02
$13.17
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$22.00
$14.38
AVG Volume (30 Days)
453.4K
1.1M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
11.69%
EPS Growth
N/A
4.41
EPS
N/A
0.29
Revenue
N/A
N/A
Revenue This Year
$840.00
N/A
Revenue Next Year
$287.54
N/A
P/E Ratio
N/A
$45.07
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$11.77
52 Week High
$48.10
$14.93

Technical Indicators

Market Signals
Indicator
PLSE
GBDC
Relative Strength Index (RSI) 78.25 53.66
Support Level $24.27 $12.70
Resistance Level N/A $13.45
Average True Range (ATR) 3.09 0.24
MACD 0.62 0.01
Stochastic Oscillator 98.50 61.69

Price Performance

Historical Comparison
PLSE
GBDC

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.

Share on Social Networks: